Fresh off a big pandemic year, Thermo Fisher announces more growth at its Midwest hub
Three months removed from the completion of its last renovation, a Thermo Fisher location is about to change again.
Thermo Fisher will spend $82.5 million to expand its St. Louis, MO operations and add another 169 jobs to its drug substance manufacturing facility. The drug substance will be used in treatments for cancer, Covid-19 and other life-threatening diseases, the company said in a press release.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,700+ biopharma pros reading Endpoints daily — and it's free.